These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26623150)

  • 21. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
    Kabay S; Canbaz Kabay S; Cetiner M; Mestan E; Sevim M; Ayas S; Ozden H; Ozisik Karaman H
    Urology; 2016 Jan; 87():76-81. PubMed ID: 26436213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with overactive bladder symptom improvement after 1 year of monthly percutaneous tibial nerve stimulation therapy.
    Pincus J; Rostaminia G; Chang C; Gafni-Kane A; Goldberg RP
    Neurourol Urodyn; 2019 Aug; 38(6):1676-1684. PubMed ID: 31107570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of electrical stimulation and posterior tibial nerve stimulation in the treatment of overactive bladder syndrome.
    Gungor Ugurlucan F; Onal M; Aslan E; Ayyildiz Erkan H; Kizilkaya Beji N; Yalcin O
    Gynecol Obstet Invest; 2013; 75(1):46-52. PubMed ID: 23171636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial.
    Peters KM; Carrico DJ; Perez-Marrero RA; Khan AU; Wooldridge LS; Davis GL; Macdiarmid SA
    J Urol; 2010 Apr; 183(4):1438-43. PubMed ID: 20171677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study.
    Boudaoud N; Binet A; Line A; Chaouadi D; Jolly C; Fiquet CF; Ripert T; Merol ML
    J Pediatr Urol; 2015 Jun; 11(3):138.e1-10. PubMed ID: 25979217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V; Guzmán R; Naser M; Aguilera A; Narvaez S; Castro A; Swift S; Digesu GA
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
    Sherif H; Khalil M; Omar R
    Can J Urol; 2017 Jun; 24(3):8838-8846. PubMed ID: 28646940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous tibial nerve stimulation versus tolterodine for overactive bladder in women: a randomised controlled trial.
    Preyer O; Umek W; Laml T; Bjelic-Radisic V; Gabriel B; Mittlboeck M; Hanzal E
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():51-6. PubMed ID: 26073262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term results of the efficacy of percutaneous tibial nerve stimulation on urinary symptoms and its financial cost.
    Kurdoğlu Z; Carr D; Harmouche J; Ünlü S; Kılıç GS
    J Turk Ger Gynecol Assoc; 2018 Mar; 19(1):7-10. PubMed ID: 29503256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of the percutaneous tibial nerve stimulation in the treatment of lower urinary tract symptoms].
    Kozma B; Majoros A; Pytel Á; Póka R; Takács P
    Orv Hetil; 2018 Oct; 159(43):1735-1740. PubMed ID: 30346235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM; Carrico DJ; MacDiarmid SA; Wooldridge LS; Khan AU; McCoy CE; Franco N; Bennett JB
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results.
    Canbaz Kabay S; Kabay S; Mestan E; Cetiner M; Ayas S; Sevim M; Ozden H; Karaman HO
    Neurourol Urodyn; 2017 Jan; 36(1):104-110. PubMed ID: 26352904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous Tibial Nerve Stimulation in Diabetic and Nondiabetic Women With Overactive Bladder Syndrome: A Retrospective Cohort Study.
    Zeno A; Handler SJ; Jakus-Waldman S; Yazdany T; Nguyen JN
    Female Pelvic Med Reconstr Surg; 2021 Nov; 27(11):686-690. PubMed ID: 34608031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.
    Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
    Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    van der Pal F; van Balken MR; Heesakkers JP; Debruyne FM; Bemelmans BL
    BJU Int; 2006 Mar; 97(3):547-50. PubMed ID: 16469023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of percutaneous tibial nerve stimulation on adult patients with overactive bladder syndrome: a systematic review.
    Moossdorff-Steinhauser HF; Berghmans B
    Neurourol Urodyn; 2013 Mar; 32(3):206-14. PubMed ID: 22907807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What Is New in Neuromodulation for Overactive Bladder?
    Tutolo M; Ammirati E; Van der Aa F
    Eur Urol Focus; 2018 Jan; 4(1):49-53. PubMed ID: 29773501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posterior tibial nerve stimulation for treating neurologic bladder in women: a randomized clinical trial.
    Eftekhar T; Teimoory N; Miri E; Nikfallah A; Naeimi M; Ghajarzadeh M
    Acta Med Iran; 2014; 52(11):816-21. PubMed ID: 25415813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.